Vancomycin: pharmacokinetics and administration regimens in neonates.
about
Pharmacokinetics of cephalosporins in the neonate: a reviewPopulation pharmacokinetics and dosing regimen design of milrinone in preterm infants.Prospective validation of neonatal vancomycin dosing regimens is urgently needed.Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrationsPopulation pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.Anti-infective use in children and pregnancy: current deficiencies and future challenges.Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenationHigh variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination.Optimization of vancomycin dosing in very low-birth-weight preterm neonates.Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship.Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearanceClinical pharmacokinetics of vancomycin in the neonate: a reviewCoagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?Commentary: Continuous infusion of vancomycin in neonates: to use or not to use remains the question.Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates.Antibiotics and antifungals in neonatal intensive care units: a review.Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in NeonatesMeropenem pharmacokinetics in the newborn.Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Dosage individualization in children: integration of pharmacometrics in clinical practice.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.How to use vancomycin optimally in neonates: remaining questions.Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients.Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.Optimizing the Use of Antibacterial Agents in the Neonatal Period.Assessment of initial vancomycin dosing in neonatesVancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review.Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.Elevated serum tobramycin concentrations after treatment with tobramycin inhalation in a preterm infant.Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.Monitoring intraventricular vancomycin for ventriculostomy access device infection in preterm infants.Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.Altered cardiovascular control in preterm infants with bronchopulmonary dysplasia.
P2860
Q27008185-50885F18-839A-47C5-BB84-E9CC6BA0C3AEQ33243169-46BABCEB-3B1D-4C1F-AB17-65B249089C1BQ33906451-A851A155-DE13-4CBD-842C-CD0328649B8EQ34014285-00B0487C-D07C-4A51-BA01-F922913B3F0DQ34381352-DBDFB931-5F12-489C-8869-57DAFBD76B4CQ35023696-B206B75C-84E9-429F-86EF-F5065A479105Q35161181-69D9847B-24CA-460D-B714-891A67550259Q35532010-B0F48A9F-3730-4DBD-BD03-DBB6AC0957BEQ35564749-5D42902B-37A9-4146-B94A-DC376203D806Q35634083-7CE23A6E-F7AD-473A-81CE-E1DF10638486Q36024899-562C9D0E-72EA-4107-A346-78FAA6290D48Q36104107-E52DA3A7-A98A-42DC-9987-6942745184A7Q36216479-863589B7-C7CD-463D-9A32-83CA1E05E174Q36452357-6C333CBA-F076-4DEF-A985-CC03447FA880Q36571794-95B8F647-D05F-4362-829C-78D167397113Q36729959-96458F2A-1F8E-4882-AF64-631149D33337Q36730100-6E0FB3E1-170E-4D30-B444-8731B7BD27B6Q36740036-9A9D168A-C650-4734-8458-8494A8476835Q37231685-66EDAC90-B51C-4B16-ABD0-E3B064EEACAAQ37333159-39637653-0313-4086-B0C4-5FA2EAF649D4Q37712974-F1641504-6F8A-4B7D-9327-765F32C062DFQ38215682-5AD94FC9-FF18-4AD6-99D6-F8019E10F21FQ38240055-B5B3E396-1672-4A52-B7E7-A645E5398285Q38258649-80982017-26AA-42A1-A950-993B24F4306DQ38569678-A959DA9D-5C63-41F0-99F6-393AF633BBE8Q38594191-7DB2BD01-E8EE-47BF-ABDB-630DC2A5374AQ38610672-9F0937C9-C5AC-48CC-9939-2CBA09ECB4EBQ38714060-69956ADC-3465-425A-B64D-2970A5EA7F60Q38922653-EF48A34D-A490-4C11-BA10-032CD61702A4Q39110114-5B3238D9-7704-441C-B3E3-D634D329A363Q39424620-4A01F6BF-3378-4E18-98FD-3DC0D1219C52Q40182576-56989684-8CE0-43D9-AE7E-47D271B663BDQ40749709-70A3B5A0-DD45-49B7-BA73-AC13FD0179E5Q40979549-E4B25610-9E99-4430-B36F-F8EE51CF1868Q42282104-6C4CF44E-378B-49C3-994B-54756EE82063Q46521204-6A04A9BD-8E2B-4162-B1DC-D44D9BE0345AQ47222670-2CF709ED-C4A3-498F-8DD3-2079D59BEDA3Q47413061-D6AC4030-303B-403F-99D8-6B0E5EE70595Q47926195-04B6E3AD-FFC0-4D34-9F0C-B292F39BCF5FQ48472628-4EC4EFAE-6F6A-4120-99FD-C72CB8078DD3
P2860
Vancomycin: pharmacokinetics and administration regimens in neonates.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vancomycin: pharmacokinetics and administration regimens in neonates.
@ast
Vancomycin: pharmacokinetics and administration regimens in neonates.
@en
type
label
Vancomycin: pharmacokinetics and administration regimens in neonates.
@ast
Vancomycin: pharmacokinetics and administration regimens in neonates.
@en
prefLabel
Vancomycin: pharmacokinetics and administration regimens in neonates.
@ast
Vancomycin: pharmacokinetics and administration regimens in neonates.
@en
P2093
P1476
Vancomycin: pharmacokinetics and administration regimens in neonates.
@en
P2093
Johan W Mouton
John N van den Anker
Matthijs de Hoog
P304
P356
10.2165/00003088-200443070-00001
P577
2004-01-01T00:00:00Z
P6179
1019286597